Literature DB >> 35190659

Monoclonal proteinuria predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100.

Alissa Visram1,2, S Vincent Rajkumar2, Prashant Kapoor2, Angela Dispenzieri2, Martha Q Lacy2, Morie A Gertz2, Francis K Buadi2, Suzanne R Hayman2, David Dingli2, Taxiarchis Kourelis2, Wilson Gonsalves2, Rahma Warsame2, Eli Muchtar2, Nelson Leung3, Robert A Kyle2, Shaji K Kumar4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35190659      PMCID： PMC9064933          DOI： 10.1038/s41375-022-01529-w

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   12.883


× No keyword cloud information.
  1 in total

1.  A case of tetramer Bence Jones proteinaemia.

Authors:  H M Grey; P F Kohler
Journal:  Clin Exp Immunol       Date:  1968-03       Impact factor: 4.330
  1 in total
  2 in total

Review 1.  Smoldering multiple myeloma current treatment algorithms.

Authors:  S Vincent Rajkumar; Shaji Kumar; Sagar Lonial; Maria Victoria Mateos
Journal:  Blood Cancer J       Date:  2022-09-05       Impact factor: 9.812

2.  Pathologic light chain amyloidosis oligomer detection in urinary extracellular vesicles as a diagnostic tool for response and progression of disease.

Authors:  Shawna A Cooper; Christopher J Dick; Pinaki Misra; Nelson Leung; Carrie A Schinstock; Marina Ramirez-Alvarado
Journal:  Front Oncol       Date:  2022-10-04       Impact factor: 5.738
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.